Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 18/20 | 0.49 |
| ▸ | CNR2 | P34972 | 11/20 | 0.49 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4831399 | 1.00 | CNR1 (0.49) | CNR1CNR2FDFT1 | |
| SCHEMBL5203472 | 0.79 | RAB9A (0.38) | CNR1CNR2FDFT1 | |
| SCHEMBL4821601 | 0.78 | CNR1 (0.54) | CNR1CNR2FDFT1 | |
| SCHEMBL3520706 | 0.77 | FDFT1 (0.48) | CNR1CNR2FDFT1 | |
| SCHEMBL4825435 | 0.76 | CNR1 (0.57) | CNR1CNR2FDFT1 | |
| Hydrochloric Acid SCHEMBL4826836 | 0.75 | CNR1 (0.56) | CNR1CNR2FDFT1 | |
| SCHEMBL4829888 | 0.75 | CNR1 (0.56) | CNR1CNR2FDFT1 | |
| SCHEMBL4825568 | 0.75 | CNR1 (0.50) | CNR1CNR2FDFT1 | |
| SCHEMBL14064692 | 0.75 | CNR1 (0.50) | CNR1CNR2FDFT1 | |
| SCHEMBL3519984 | 0.74 | FDFT1 (0.46) | CNR1CNR2FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7423067-B2 | N-(3,4-diphenyl-2-butyl)cyclopentancarboxamide derivatives such as N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-3-benzoyl-cyclopentane-carboxamide; used for treating conditions including psychological disorders, eating disorders and substance abuse | MERCK & CO., INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-7423067-B2 | N-(3,4-diphenyl-2-butyl)cyclopentancarboxamide derivatives such as N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-3-benzoyl-cyclopentane-carboxamide; used for treating conditions including psychological disorders, eating disorders and substance abuse | MERCK & CO., INC. (US) | 2008-09-09 | — | — | US | disclosed |